Mauri, Tommaso
,
Yoshida, Takeshi
Bellani, Giacomo
Goligher, Ewan C.
Carteaux, Guillaume
Rittayamai, Nuttapol
Mojoli, Francesco
Chiumello, Davide
Piquilloud, Lise
Grasso, Salvatore
Jubran, Amal
Laghi, Franco
Magder, Sheldon
Pesenti, Antonio
Loring, Stephen
Gattinoni, Luciano
Talmor, Daniel
Blanch, Lluis
Amato, Marcelo
Chen, Lu
Brochard, Laurent
Mancebo, Jordi
Funding for this research was provided by:
Canadian Institutes of Health Research (Post-Doctoral Fellowship)
CIBER Enfermedades Respiratorias (ISCIII PI13/02204-FEDER)
Research Institute of the Hospital for Sick Children (RESTRACOMP training award)
Keenan research centre (Keenan Chair in Critical Care and Acute Respiratory Failure)
Article History
Received: 28 February 2016
Accepted: 17 May 2016
First Online: 22 June 2016
Compliance with ethical standards
:
: E. Goligher is supported by a Post-Doctoral Fellowship from the Canadian Institutes of Health Research and by ISCIII PI13/02204-FEDER, CIBER Enfermedades Respiratorias to L. Blanch; T. Yoshida is funded by a RESTRACOMP training award from the Research Institute of the Hospital for Sick Children, Toronto, ON, Canada. L. Brochard is the Keenan Chair in Critical Care and Acute Respiratory failure, Keenan Research Centre, Toronto.
: F. Mojoli, D. Chiumello and L. Gattinoni were involved in a University research spin-off for the development of Nutrivent [Sidam, Mirandola (MO), Italy]. L. Blanch is inventor of one Corporació Sanitaria Parc Taulí-owned U.S. patent (US Patent No. 12/538,940): “Method and system for managed related patient parameters provided by a monitoring device”. L. Blanch owns stock options of BetterCare S.L., which is a research and development spin off of Corporació Sanitària Parc Taulí (Spain). Outside the submitted work, J. Mancebo reports grants from Covidien, non-financial support from Maquet and General Electric and personal fees from Covidien, Hamilton, Braun, Air-Liquide, Faron, and A-Lung. Outside the submitted work, L. Brochard reports grants from Covidien, Fisher Paykel, non-financial support from Maquet, Philips and General Electric and personal fees from Covidien and Maquet. All other authors declare that they do not have any conflicts of interest to declare.
Free to read: This content has been made available to all.